MedPath

Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the Rule

Completed
Conditions
Serous Ovarian Carcinoma
Low Grade Serous Ovarian Carcinoma
Interventions
Other: Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
Registration Number
NCT05741554
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Investigators studied a population of 28 low grade serous ovarian carcinoma treated in Hospices civils de Lyon between 2000 and 2022. The primary objective is to determinate the rate of myometrial involvement by the cancer at pathology examination. Then, investigators compared patients with or without myometrial involvement : survival parameters, predictive factors of myometrial involvement (age, CA 125 level, surgery characteristics, pathology characteristics).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
No myometrial involvementRate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.Absence of myometrial involvement by cancer metastasis after pathology examination
Myometrial involvementRate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.Myometrial involvement by cancer metastasis after pathology examination
Primary Outcome Measures
NameTimeMethod
Percentage of myometrial involvementAfter pathology examination, average 2 to 3 weeks after cytoreductive surgery

Myometrial involvement after pathology examination

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospices civils de Lyon

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath